✦ LIBER ✦

An evaluation of the possible interaction of gastric acid suppressing medication and the EGFR tyrosine kinase inhibitor erlotinib

✍ Scribed by Hilton, J.F.; Tu, D.; Seymour, L.; Shepherd, F.A.; Bradbury, P.A.

Book ID: 123477470
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 770 KB
Volume: 82
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2013.06.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O-247 Molecular mechanisms of sensitivit

O-247 Molecular mechanisms of sensitivity and resistance to the HER1/EGFR-tyrosine kinase inhibitor erlotinib (Tarceva™)

✍ Perez-Soler, Roman; Dai, Qun; Ling, Yi-He; Lee, Marie; Kroog, Glenn; Zou, Yiyu; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 178 KB

First-line treatment of EGFR-mutant non-

First-line treatment of EGFR-mutant non-small-cell lung cancer: the role of erlotinib and other tyrosine kinase inhibitors

✍ Neal, Joel; Nguyen, Kim-Son H. 📂 Article 📅 2012 🏛 Dove Press Ltd. 🌐 English ⚖ 228 KB

ChemInform Abstract: Tyrosine Kinase Inh

ChemInform Abstract: Tyrosine Kinase Inhibitors. Part 9. Synthesis and Evaluation of Fused Tricyclic Quinazoline Analogues as ATP Site Inhibitors of the Tyrosine Kinase Activity of the Epidermal Growth Factor Receptor (EGFR).

✍ G. W. REWCASTLE; B. D. PALMER; A. J. BRIDGES; H. D. H. SHOWALTER; L. SUN; J. NEL 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 32 KB

Anti-tumor activity of the combination o

Anti-tumor activity of the combination of cetuximab, an anti-EGFR blocking monoclonal antibody and ZD6474, an inhibitor of VEGFR and EGFR tyrosine kinases

✍ Maria Pia Morelli; Tina Cascone; Teresa Troiani; Concetta Tuccillo; Roberto Bian 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB

## Abstract Purpose: The epidermal growth factor receptor (EGFR) autocrine pathway plays an important role in cancer cell growth. Vascular endothelial growth factor A (VEGF‐A) is a key regulator of tumor‐induced endothelial cell proliferation and vascular permeability. ZD6474 is an orally available

The growth inhibitory effect of lapatini

The growth inhibitory effect of lapatinib, a dual inhibitor of EGFR and HER2 tyrosine kinase, in gastric cancer cell lines

✍ Jin Won Kim; Hwang-Phill Kim; Seock-Ah Im; Soyeong Kang; Hyung Seok Hur; Young-K 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 407 KB

PD153035, an EGF receptor (EGFr) tyrosin

PD153035, an EGF receptor (EGFr) tyrosine-kinase specific inhibitor, reverses the effect of EGF on gastric secretion and TNBS-induced colitis in rats

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 151 KB